Drugs Made Financials
| DMII Stock | 10.01 0.01 0.10% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Return On Equity | 1.04 | 1.17 |
|
| |||||
| Current Ratio | 0.18 | 0.21 |
|
|
Understanding current and past Drugs Made Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Drugs Made's financial statements are interrelated, with each one affecting the others. For example, an increase in Drugs Made's assets may result in an increase in income on the income statement.
Drugs Made Stock Summary
Drugs Made competes with Inflection Point, GigCapital7 Corp, Diamond Hill, M3 Brigade, and Axiom Intelligence. Drugs Made is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Financial Services, Financial Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | KYG2851K1040 |
| Business Address | 1 East Broward |
| Sector | Capital Markets |
| Industry | Financials |
| Benchmark | Dow Jones Industrial |
| Phone | 954 870 3099 |
Drugs Made Key Financial Ratios
| Book Value Per Share | (0.26) X | ||||
| Market Capitalization | 655.09 M |
Drugs Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Drugs Made's current stock value. Our valuation model uses many indicators to compare Drugs Made value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Drugs Made competition to find correlations between indicators driving Drugs Made's intrinsic value. More Info.Drugs Made In is rated as one of the top companies in current valuation category among its peers. It also is one of the top stocks in shares outstanding category among its peers creating about 0.10 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for Drugs Made In is roughly 9.99 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Drugs Made's earnings, one of the primary drivers of an investment's value.About Drugs Made Financials
What exactly are Drugs Made Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Drugs Made's income statement, its balance sheet, and the statement of cash flows. Potential Drugs Made investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Drugs Made investors may use each financial statement separately, they are all related. The changes in Drugs Made's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Drugs Made's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Drugs Made February 20, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Drugs Made help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Drugs Made In. We use our internally-developed statistical techniques to arrive at the intrinsic value of Drugs Made In based on widely used predictive technical indicators. In general, we focus on analyzing Drugs Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Drugs Made's daily price indicators and compare them against related drivers.
| Downside Deviation | 0.1663 | |||
| Information Ratio | (0.28) | |||
| Maximum Drawdown | 0.9098 | |||
| Value At Risk | (0.10) | |||
| Potential Upside | 0.3036 |
Complementary Tools for Drugs Stock analysis
When running Drugs Made's price analysis, check to measure Drugs Made's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Drugs Made is operating at the current time. Most of Drugs Made's value examination focuses on studying past and present price action to predict the probability of Drugs Made's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Drugs Made's price. Additionally, you may evaluate how the addition of Drugs Made to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Commodity Directory Find actively traded commodities issued by global exchanges |